摘要：目的：探讨结核性胸膜炎治疗中缩短胸水吸收时间及防止胸膜肥厚粘连的方法。方法：将104例结核性胸膜炎患者分为2组：治疗组56例，先采用中心静脉导管置入胸腔持续引流胸水1～2 d，待胸水减少时，将尿激酶注入胸膜腔；对照组48例，仅采用中心静脉导管置入胸腔持续引流胸水，而未注射尿激酶，比较2组患者治疗后胸水消失时间及胸膜粘连发生率。结果：治疗10 d后,治疗组胸水完全吸收率为92.9%(52/56)，而对照组为52.1%(25/48)；治疗组治愈后胸膜粘连肥厚发生率为16.1%(9/56)，对照组为43.8%(21/48)，两组差异均具有统计学意义。结论：胸腔注射尿激酶治疗结核性胸膜炎，可显著缩短胸水吸收时间，有效防止胸膜肥厚粘连的发生。

    关健词：胸腔注射；尿激酶；结核性胸膜炎

    The clinical analysis of 56 case of urokinase injection through indwelling thoracic atheter to treat tuberculous

    GUO Bin

    (Second People′s Hospital of Changji City， Changji 831100, China)

    Abstract： Objective： To study the clinical effect of urokinase injection through indwelling thoracic catheter in treat tuberculous encapsulated hydrothorax to retrench the course of tuberculous pleurisy and prevent pleural thickening. Methods：One hundred and four cases of tuberculous pleurisy were divided randomly into two groups. In 56 cases of the remedy group, adapted of urokinase injection through indwelling thoracic catheter for pleural effusion drainge after 1~2 days. In 48 cases of control group ......